The accepted-paper abstract reports that DeltaCata, a geometric graph neural network predicting mutation effects on enzyme kinetics, guided engineering of methyltransferase sGmOMT2. The authors report up to a sevenfold improvement in catalytic efficiency for in vitro icaritin synthesis. This experimental application goes beyond the model benchmarks; industrial-scale performance is not demonstrated by the reviewed abstract.
Technology: DeltaCata; Siamese geometric graph neural network
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The abstract reports experimental enzyme engineering and an in vitro catalytic-efficiency improvement.
- Still unknown: Full experimental methods, industrial performance and independent replication were not assessed.
- AI role: The model predicts mutation-induced kinetic changes to prioritize enzyme variants.
Evidence sources: https://www.nature.com/articles/s41467-026-79287-x
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
Bayesian optimization and a CNN, coupled to non-equilibrium molecular dynamics, selected two-angle disordered twisted multilayer graphene structures with substantially lower simulated cross-plane thermal conductivity than aligned and periodic stacks. The optimized 14-layer sequence reached 0.095 W m−1 K−1 versus 0.512 W m−1 K−1 in aligned graphene in the reported model; phonon participation ratios and dynamical structure factors support strong partial phonon localization.
Technology: Bayesian optimization (COMBO) and convolutional neural network coupled to molecular-dynamics simulations
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Bayesian optimization and a CNN, coupled to non-equilibrium molecular dynamics, selected two-angle disordered twisted multilayer graphene structures with substantially lower simulated cross-plane thermal conductivity than aligned and periodic stacks.
- Still unknown: This is a computational prediction supported by molecular-dynamics calculations, not a measured thermal-conductivity result from fabricated multilayer samples. The paper reports 80% reduction relative to aligned graphene for an optimized sequence and interprets phonon participation/structure-factor analyses as evidence of partial localization.
- AI role: Bayesian optimization selected low-conductivity twist sequences; the CNN screened the larger configuration space and proposed low-conductivity structures for subsequent molecular-dynamics evaluation.
Evidence sources: https://www.nature.com/articles/s41524-025-01678-3
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 17 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
Machine-learning analysis of untargeted serum metabolomic and lipidomic profiles from clinical pig cohorts identified lysophosphatidic acid (LPA) as a PRRSV-associated biomarker. Follow-up infection experiments reported increased LPA with autotaxin upregulation; in porcine alveolar macrophages, LPA manipulation altered RIG-I/type-I-interferon responses and viral replication. In infected pigs, targeting LPA was reported to protect against infection and associated disease outcomes.
Technology: Random-forest analysis of serum metabolomic and lipidomic profiles
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Machine-learning analysis of untargeted serum metabolomic and lipidomic profiles from clinical pig cohorts identified lysophosphatidic acid (LPA) as a PRRSV-associated biomarker.
- Still unknown: The clinical classifier and biomarker work concerns pigs, not human diagnosis. The infection challenge experiments were small (figure descriptions report five piglets per group), and cell assays were performed in vitro. The authors report that the mechanism by which LPA suppresses RIG-I remains unclear; the findings do not establish a treatment for people or broad field effectiveness in livestock.
- AI role: Random-forest analysis ranked metabolite and lipid features from clinical PRRSV-positive and negative pig cohorts and contributed to identification of LPA as the candidate biomarker. The authors then tested LPA in infection models, including cultured porcine alveolar macrophages and infected pigs, to examine host-response and disease outcomes.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11425916/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 14 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.